Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'rn 1 dihydrochloride'

Search results for: 'rn 1 dihydrochloride'

Items 1-10 of 38

Page
per page
  1. Sephin1
    A8708 Sephin1
     1 Citation
    Target: phosphatases
    Summary: Selective PPP1R15A inhibitor
      insoluble in H2O; insoluble in EtOH; ≥7.75 mg/mL
  2. PFI-1 (PF-6405761)
    A4184 PFI-1 (PF-6405761)
     1 Citation
    Target: Bromodomains
    Summary: BET inhibitor
      insoluble in H2O; insoluble in EtOH; ≥128.4 mg/mL
  3. BAY 87-2243
    B1115 BAY 87-2243
    Target: Hypoxia Inducible Factors (HIFs)
    Summary: HIF-1 inhibitor,potent and selective
  4. PJ34
    A3729 PJ34
    Target: PARP
    Summary: PARP-l inhibitor
      ≥50.9 mg/mL
  5. ZM 447439
    A4113 ZM 447439
    Target: Aurora Kinases|MEK|Src|Lck
    Summary: Aurora Kinase inhibitor,potent and selective
      ≥25.7 mg/mL
  6. DMOG
    A4506 DMOG
    Target: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)
    Summary: Competitive HIF-PH inhibitor, cell-permeable
  7. Inauhzin
    B3272 Inauhzin
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1 inhibitor
      ≥23.5 mg/mL
  8. Valproic acid
    B1251 Valproic acid
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC1 inhibitor
      ≥12.35 mg/mL
  9. C646
    B1577 C646
     1 Citation
    Target: p300
    Summary: HAT p300-CBP inhibitor,cell-permeable
      insoluble in H2O; ≥11.14 mg/mL
  10. EPZ005687
    A4171 EPZ005687
     2 Citation
    Target: EZH2
    Summary: EZH2 inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥3.86 mg/mL

Items 1-10 of 38

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 2item
  2. Aurora Kinase 4item
  3. HDAC 8item
  4. Histone Acetyltransferases 2item
  5. Histone Demethylases 1 item
  6. Histone Methyltransferase 4item
  7. HIF 2item
  8. JAK 5item
  9. PARP 3item
  10. Pim 2item
  11. Protein Ser/Thr Phosphatases 3item
  12. Sirtuin 2item
Reversibility
  1. Reversible 1 item
Target
  1. Histone Deacetylases (HDACs) 7item
  2. Aurora Kinases 4item
  3. EZH2 1 item
  4. Bromodomains 1 item
  5. FLT3 1 item
  6. MEK 1 item
  7. DOT1L 1 item
  8. Pim 2item
  9. Sir2-like Family Deacetylases (Sirtuins) 2item
  10. PP1 1 item
  11. PP2A 1 item
  12. Src 1 item
  13. Hypoxia Inducible Factors (HIFs) 1 item
  14. JAK 5item
  15. p300 1 item
  16. TNKS 1 item
  17. Topoisomerases 1 item
  18. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  19. PARP 2item
  20. phosphatases 1 item
  21. NAT10 1 item
  22. SETD7 1 item
  23. Histone Demethylases 1 item
  24. Protein Arginine Methyltransferases 1 item
  25. PP4 1 item
  26. c-RET 1 item
  27. Protein polybromo-1 1 item
  28. SMARCA4 1 item
  29. SMARCA2 1 item
  30. Lck 1 item
Reported Experiments
  1. Animal Experiments 29item
  2. Cell Experiments 21item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Breast Cancer 6item
  3. Cancer 23item
  4. Cervical Cancer 1 item
  5. Colon Cancer 2item
  6. Colon Carcinoma 1 item
  7. Colorectal Cancer 1 item
  8. Diabetes 1 item
  9. Epilepsy 1 item
  10. Glioma 1 item
  11. Hepatic Cancer 1 item
  12. Hepatocellular Carcinoma 1 item
  13. HIV Infections 1 item
  14. Inflammatory Diseases 1 item
  15. Leukemia 2item
  16. Lung Cancer 2item
  17. Lymphoma 2item
  18. Melanoma 1 item
  19. Mixed Lineage Leukemia 1 item
  20. Multiple Myeloma 2item
  21. Myelofibrosis 1 item
  22. Non-small Cell Lung Cancer 2item
  23. Ovarian Cancer 3item
  24. Pancreatic Cancer 3item
  25. Prostate Cancer 6item
  26. Psoriasis 1 item
  27. Renal Cell Carcinoma 1 item
  28. Rheumatoid Arthritis 2item